OM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Outset Medical's interest expense for the three months ended in Dec. 2024 was $ -5.8 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was $-23.9 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Outset Medical's Operating Income for the three months ended in Dec. 2024 was $ -21.9 Mil. Outset Medical's Interest Expense for the three months ended in Dec. 2024 was $ -5.8 Mil. Outset Medical did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
The historical data trend for Outset Medical's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Outset Medical Annual Data | ||||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||
Interest Expense | Get a 7-Day Free Trial | -2.89 | -1.72 | -3.57 | -12.68 | -23.87 |
Outset Medical Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Interest Expense | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-3.42 | -5.97 | -6.01 | -6.07 | -5.83 |
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-23.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Outset Medical (NAS:OM) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Outset Medical's Interest Expense for the three months ended in Dec. 2024 was $-5.8 Mil. Its Operating Income for the three months ended in Dec. 2024 was $-21.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was $200.1 Mil.
Outset Medical's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as
Outset Medical did not have earnings to cover the interest expense. |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
John L. Brottem | officer: General Counsel | 3052 ORCHARD DR., SAN JOSE CA 95134 |
Leslie Trigg | director, officer: President & CEO | C/O OUTSET MEDICAL, 1830 BERING ROAD, SAN JOSE CA 95112 |
Marc Nash | officer: SVP, Operations and R&D | 3052 ORCHARD DRIVE, SAN JOSE CA 95134 |
Nabeel Ahmed | officer: Interim CFO | 3052 ORCHARD DRIVE, SAN JOSE CA 95134 |
D Keith Grossman | director | |
Jean-olivier Racine | officer: Chief Technology Officer | 3052 ORCHARD DRIVE, SAN JOSE CA 95134 |
Steven S. Williamson | officer: Chief Commercial Officer | C/O HOLOGIC, INC., BEDFORD MA 01730 |
Stacey L. Porter | officer: Chief People Officer | 3052 ORCHARD DRIVE, SAN JOSE CA 95134 |
Martin Vazquez | officer: Chief Operating Officer | 3052 ORCHARD DR., SAN JOSE CA 95134 |
James F. Hinrichs | director | 3750 TORREY VIEW COURT, SAN DIEGO CA 92130 |
Dale E Jones | director | C/O HUGHES SUPPLY INC, 20 N ORANGE AVE, ORLANDO FL 32801 |
Rebecca Chambers | officer: Chief Financial Officer | 3052 ORCHARD DR., SAN JOSE CA 95134 |
Catherine M. Szyman | director | C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614 |
Warburg Pincus Llc | director, 10 percent owner | 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
Warburg Pincus X, L.p. | director, 10 percent owner | C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
From GuruFocus
By Marketwired • 02-03-2025
By GuruFocus News • 02-19-2025
By GuruFocus News • 11-13-2024
By GuruFocus News • 02-19-2025
By Marketwired • 10-23-2024
By GuruFocus News • 02-12-2025
By GuruFocus News • 01-31-2025
By GuruFocus News • 11-05-2024
By PRNewswire • 10-28-2024
By Marketwired • 02-06-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.